5 Canadian Cannabis Stocks for Your Portfolio


Unlike its southern neighbour, Canada legalized medical Cannabis nationwide back in 2001. That means that the industry has evolved a lot more and is not plagued with restraints across state borders, as is the case in the U.S, where there are 29 states (and Washington, D.C.), where Cannabis is allowed for medical use. Further, Canada introduced the Cannabis Act recently, and the bill to legalize recreational cannabis use is expected to pass by July of 2018. However, in America, the immediate future for legal cannabis was in question after Attorney General Jeff Sessions reversed an Obama-era law that protected states willing to liberalize legal Cannabis laws.

Cannabis Stocks Canada

There a lot of risks associated with the U.S market, shareholders could get a share of the cannabis action by investing in Canadian stocks traded in the country in the over-the-counter (OTC) markets. Most of these stocks can be identified as penny stocks so that any investment may carry a notably higher risk component. Here’s are some of those companies:

1. Canopy Growth Corp.

Market Cap: $6.10 billion

Canopy (NYSE: CGC) is touted as Canada’s first unicorn in the Cannabis market. The company sells its goods under different labels; the label ‘Tweed’ has had the most recognition because of its affiliation with rapper Snoop Dogg. The company enlisted on NewYork Stock Exchange May 24, 2018.

2. Aurora Cannabis

Market Capitalization: $5.33 billion

Aurora Cannabis Inc. debuted on the Canadian venture stock exchange (TSX) in October 2016. In addition to producing dry cannabis, Aurora got a license to sell cannabis oil in January 2017. It has been in the over-the-counter market for a long time, returning 347% over a period of one-year. In May 2018, Aurora Cannabis bought MedReleaf Corp. for $2.5 billion. As of June 7 MedReleaf, 2018, has a market capitalization of $2.92 billion and has seen a 292% increase in their stock over last few years.

3. Aphria Inc.

Market Capitalization: $2.53 billion

The corporation defines itself as one of the lowest cost producers of Cannabis. Aphria produces dry cannabis as well as cannabis oil of varying properties and strength. Moreover, in April 2018, their stock sky-rocketed after the company stated that it had struck a deal to sell its goods through the online website of Shoppers Drug Mart, a major Canadian pharmacy chain. Over the last couple of years, the stock has risen by 146%.

 4. PharmaCan Capital/The Cronos Group

Market Capitalization: $1.37 billion

This corporation is in the business of investing in Cannabis growers and companies in the Cannabis business. PharmaCan’s portfolio presently comprises of six companies. It owns two of these corporations simply – the rest it holds a minority stake in. Over the last couple of years, the stock has risen to almost 502%.

5. The Hydropothecary Corporation

Market Capitalization: $965.05 million

The Hydropothecary Corporation (OTC: THCX) is the only licensed medical Cannabis producer headquartered in Quebec. Moreover, the company is preparing the launch of their new brand, HEXO, which will focus on recreational Cannabis use. Hydropothecary Corporation’s stock has risen up to 203% over the past year.

Budderweeds is an online cannabis dispensary. We mail order deliveries across Canada. We ensure discretion with smell proof and plain label packaging. All data is encrypted, so privacy is safe. We offer a guarantee if the package isn’t delivered.

We provide a wide range of hand-made cannabis product such as our THC infused candies, numerous strains of craft grown flowers, high potency extracts, and vaporizer pens.

Choose to add Budderweeds cannabis products to your day or night and realize the benefits of our premium brand. Packages are delivered discreetly to your door in a couple of days, but only to Canadian addresses.